- Home
- XPON vs INM Comparison
XPON vs INM Comparison
Compare XPON & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- INM
- Stock Information
- Founded
- XPON 2016
- INM 1981
- Country
- XPON United States
- INM Canada
- Employees
- XPON N/A
- INM N/A
- Industry
- XPON Electronic Components
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- XPON Technology
- INM Health Care
- Exchange
- XPON Nasdaq
- INM Nasdaq
- Market Cap
- XPON 1.9M
- INM 2.3M
- IPO Year
- XPON 2022
- INM N/A
- Fundamental
- Price
- XPON $0.92
- INM $2.82
- Analyst Decision
- XPON
- INM
- Analyst Count
- XPON 0
- INM 0
- Target Price
- XPON N/A
- INM N/A
- AVG Volume (30 Days)
- XPON 91.0K
- INM 40.0K
- Earning Date
- XPON 03-27-2025
- INM 05-13-2025
- Dividend Yield
- XPON N/A
- INM N/A
- EPS Growth
- XPON N/A
- INM N/A
- EPS
- XPON N/A
- INM N/A
- Revenue
- XPON $4,498,181.00
- INM $4,832,013.00
- Revenue This Year
- XPON N/A
- INM N/A
- Revenue Next Year
- XPON $66.62
- INM N/A
- P/E Ratio
- XPON N/A
- INM N/A
- Revenue Growth
- XPON N/A
- INM N/A
- 52 Week Low
- XPON $0.87
- INM $2.42
- 52 Week High
- XPON $349.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- XPON 25.91
- INM 42.80
- Support Level
- XPON $0.87
- INM $2.66
- Resistance Level
- XPON $0.94
- INM $2.89
- Average True Range (ATR)
- XPON 0.09
- INM 0.22
- MACD
- XPON -0.01
- INM 0.04
- Stochastic Oscillator
- XPON 10.02
- INM 44.62
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.